PatientsVille.com Logo

Anxiety disorder and Citalopram

PatientsVille

Anxiety Disorder Symptoms and Causes

A phobia is a type of anxiety disorder. It is a strong, irrational fear of something that poses little or no real danger.

There are many specific phobias. Acrophobia is a fear of heights. Agoraphobia is a fear of public places, and claustrophobia is a fear of closed-in places. If you become anxious and extremely self-conscious in everyday social situations, you could have a social phobia. Other common phobias involve tunnels, highway driving, water, flying, animals and blood.

People with phobias try to avoid what they are afraid of. If they cannot, they may experience

  • Panic and fear
  • Rapid heartbeat
  • Shortness of breath
  • Trembling
  • A strong desire to get away

Phobias usually start in children or teens, and continue into adulthood. The causes of specific phobias are not known, but they sometimes run in families.

Treatment helps most people with phobias. Options include medicines, therapy or both.

NIH: National Institute of Mental Health

Check out the latest treatments for anxiety disorder

anxiety disorder treatment research studies

Citalopram clinical trials, surveys and public health registries


Find Drug Side Effect reports



Citalopram Side Effects

Completed Suicide (706)
Anxiety (365)
Dizziness (361)
Depression (356)
Fall (355)
Overdose (351)
Confusional State (350)
Toxicity To Various Agents (338)
Hyponatraemia (322)
Nausea (320)
Serotonin Syndrome (310)
Agitation (305)
Headache (300)
Cardiac Arrest (298)
Convulsion (272)
Tremor (261)
Suicide Attempt (259)
Respiratory Arrest (253)
Fatigue (241)
Electrocardiogram Qt Prolonged (241)
Suicidal Ideation (189)
Vomiting (188)
Malaise (188)
Condition Aggravated (186)
Diarrhoea (185)
Intentional Overdose (184)
Somnolence (163)
Insomnia (156)
Feeling Abnormal (150)
Loss Of Consciousness (145)
Dyspnoea (132)
Hyperhidrosis (128)
Hypotension (127)
Aggression (126)
Hallucination (125)
Asthenia (116)
Syncope (114)
Cardio-respiratory Arrest (112)
Restlessness (112)
Grand Mal Convulsion (111)
Pyrexia (109)
Disturbance In Attention (105)
Disorientation (99)
Depressed Level Of Consciousness (99)
Tachycardia (99)
Abdominal Pain (97)
Coma (96)
Palpitations (95)
Death (93)
Hypokalaemia (90)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

<b>Describe Your Citalopram Experience Here:</b>Caused compulsive shopping and gambling.

13 days and all is well.... slight stomach discomfort, but feeling so much better

1st day was hell, had about every side effect in the book. 2nd day was better, side effects decreased greatly 5th day is going well so far- feeling a little 'edgy &amp; apprehensive' but better than the alternative

After the drugs my doctor gave me i got bad side effecs of concerta nou they poet me on lexamil 5mg anty dipresints nou pleas tell my if ther any side efecks of this drug

And i only took one 20mg tablet.. NEVER AGAIN!!! feel like iam going deaf the ringing bad it's like R2D2 from starwars in my right ear

At the beginer I was very ancius but now I am better ,I have one month that I am uses and combine with ritrovil 2 mg in the evening . I want to know ,will have I side effect from the liver? because I am with hepatiti c or any other problem ?Please

Been on citalopram 40 mg four years. Side effects, 20 lb weight gain, dry mouth. Needed toincrease from 20 to 40 mg to be effective. Wouldn't recommend to anyone as it is hard to get off this medication.&nb

Buspirone hydrochloride has made my symptoms worse should i stop taking them

Can apo-escitalopram effect seamen. Can it make it more acidic? Does it come out in it all?

Citalopram is making my ears ring bad. like sound feedback aswell fell like iam going mad

hi im 14 weeks pregnant and have taken 5mg cipralex for five days now at night for depression and anxiety,i feel better though very sleepy even during the day but im concerned for my unborn baby

I have been put on Molipaxin 3 weeks ago, I have dry mouth, hair loss and my panic attacks were showing no signs of improvement. Dr increased it to 100mg and put me onto Lamictin. I am not bi polar nor epileptic. My disorder ist algora phoebia. I a

Side effects I have from Nadolol are confusion, dizziness, lightheaded, increased depression and anxiety, and mild nausea.

Although it did help my acne. Id rather have acne thanbthe horrible stomach problems and anxiety.

Emotional Anxciety then chest pain, jaw pain on left side and headaches, I am not taking it no more. there has to be something else less tramatising to my system. It was bad enugh that i was at work when the emotional anxiety hit. not cool at all.

Had complete hysterectomy in 1999 and developed cystis acne. Was 34 at the time. Prescribed accutane for 9 months. Worked great with the usual side effects-dry lips. Now 11 years later, I am suffering from a severe anxiety disorder with body dimorph

When I 1st took Levothyroxine it made me very, very anxious. My anxiety seemed to get a little better, after my Dr found that I needed 112 mg for my condition. I have been taking it for about 2 years, but in the last 6 months my anxiety is back, and

i had pounding heart and severe depression and anxiety while takeing candersartan. im waiting to see a cardioligist to see if i have done any damage. feel so much better now i have stopped takeing them

<strong>I was put on Metoprolol ER 2 years ago after having cancer. I was </strong><span style='text-decoration: underline;'>tired all day could not sleep at night, had anxiety attacks, co

Endosulfan can causes genetic disorder,body disability, impotency in Male &amp; Female both.. So be careful say no to Endosulfan &amp; other pesticides

Anxiety Disorder Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Escitalopram PIndolol ONset of Action
Condition: Unipolar Depression
Interventions: Drug: Escitalopram, pindolol;   Drug: Escitalopram
Outcome Measures: MADRS score change between baseline and 2 weeks of treatment;   Response/remission (MADRS) at 6 weeks;   Adverse events;   Correlation of drug level of pindolol and/or Escitalopram and clinical outcome (primary outcome) between treatment groups
2 Recruiting Lexapro®'s Efficacy After Dose Escalation in Remission Study
Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Outcome Measures: Montgomery-Åsberg Depression Rating Scale (MADRS);   Hamilton Depression Rating Scale-17 items (HAM-D);   Hamilton Anxiety Rating Scale (HAM-A);   Clinical Global Impression-severity (CGI-S);   Clinical Global Impression-Improvement (CGI-I);   Beck's Depression Inventory(BDI);   WHO Quality Of Life scale Abbreviated Version(WHOQOL-BREF);   Clinically Useful Depression Outcome Scale (CUDOS);   Short From-36 Health survey (SF-36 Health survey)
3 Unknown  Circadian Effects of Escitalopram
Condition: Depression
Intervention: Drug: placebo/Escitalopram
Outcome Measures: Resetting effect of Escitalopram on the circadian pacemaker;   Correlation between improvement in depression with Escitalopram and the degree of realignment between the timing of sleep and the timing of the biological clock.
4 Recruiting Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder
Conditions: Irritable Bowel Syndrome;   Panic Disorder
Intervention: Drug: Escitalopram
Outcome Measures: Gastrointestinal Symptom Rating Scale (GSRS).;   State Trait Anxiety Inventory (STAI).
5 Recruiting Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
Conditions: Major Depressive Disorder;   Major Depressive Disorder, Recurrent, Unspecified;   Major Depressive Disorder, Single Episode, Unspecified
Interventions: Drug: Escitalopram oxalate;   Device: transcranial direct current stimulation
Outcome Measures: Change in Hamilton Rating Scale for Depression, 17 items (HAMD17);   Change in Montgomery-Asberg Depression Rating Scale (MADRS);   Change in Beck Depression Inventory (BDI);   Hamilton Rating Scale for Depression, 17 items (HAMD17)
6 Not yet recruiting Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: Agomelatine;   Drug: Escitalopram
Outcome Measures: Change from baseline in markers of sympathetic nervous system activity.;   Change from baseline in the magnitude of morning surge in blood pressure.;   To determine the association between sympathetic nervous system activity and left ventricular hypertrophy.;   Change from baseline in insulin resistance.;   Change from baseline on markers of cardiac risk.
7 Unknown  The Effects of Escitalopram on Cytokines
Condition: Depression
Intervention: Drug: Escitalopram
Outcome Measures: The changes in cytokines;   The changes in Hamilton Depression Rating Scale
8 Unknown  Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
Conditions: Depression;   Continuous Antidepressant Abuse;   Adverse Reaction to Drug
Intervention: Drug: Escitalopram
Outcome Measures: antidepressant response at 2,4,6,8 weeks A/E monitoring at 1,2,4,6,8 weeks;   biological value at 0 week and 8 weeks
9 Unknown  Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)
Condition: Major Depression
Interventions: Drug: Escitalopram;   Drug: nortriptyline
Outcome Measures: Hamilton depression rating scale;   Drop out due to side-effects of drugs
10 Unknown  Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain
Conditions: Low Back Pain;   Depression
Interventions: Drug: Escitalopram;   Drug: Placebo
Outcome Measures: In comparison to placebo-treated patients, patients with treated with Cipralex report a significant reduction in depressive symptoms (>= 50% HAMD score) after 4 weeks of treatment.;   In comparison to placebo, subjects treated with Cipralex report a significant reduction in pain intensity (>= 50% reduction of pain questionnaire score or VAS) after 12 weeks of treatment.;   In comparison with placebo, subjects treated with Cipralex report a significant improvement in physical and everyday functioning after 12 weeks of treatment.;   Personality traits do not have a significant influence on outcome regarding depressive traits, pain intensity and functioning.;   Personality disorders are significantly influencing worse outcome regarding depressive traits, pain intensity and functioning.
11 Recruiting A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom
Condition: Depressive Disorder, Major
Intervention: Drug: Escitalopram
Outcome Measures: Change From Baseline in Quality of Life Enjoyment and Satisfaction Questionnaire, Short Form (Q-LES-Q-SF);   Change From Baseline in Sheehan Disability Scale (SDS);   Remission Rate at Week 8;   Onset of Effect Rate at Week 1;   Onset of Effect Rate at Week 2;   Change From Baseline to Week 8 in Montgomery-Asberg Depression Rating Scale (MADRS) Scores;   Change From Baseline to Week 8 in Hamilton Anxiety Scale (HAMA) Scores;   Change From Baseline to Week 8 in Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) Scores
12 Unknown  Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression
Condition: Chronic Depression
Interventions: Other: CBASP psychotherapy;   Drug: Escitalopram
Outcome Measures: Depressive symptomatology after 8 weeks after randomization as measured by the MADRS;   Depressive symptoms and remission 28 weeks after randomization; social, interpersonal and work function 28 weeks after randomization
13 Recruiting Brain Aging and Treatment Response in Geriatric Depression
Conditions: Mild Neurocognitive Disorder;   MCI;   Depression
Interventions: Drug: Escitalopram;   Drug: Memantine;   Drug: Placebo
Outcome Measures: Change in Hamilton Depression Rating Scale (HDRS) scores;   Change in cognitive domain scores
14 Not yet recruiting The ISLAND Study: InSuLa Assessed Needs for Depression
Condition: Depression
Interventions: Drug: Escitalopram;   Behavioral: Cognitive Behavioral Therapy;   Other: Combination treatment (Escitalopram + CBT)
Outcome Measures: Remission from major depressive episode;   Response to treatment
15 Unknown  Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy
Condition: Marijuana Dependence
Intervention: Drug: Escitalopram
Outcome Measures: Clean urine THC samples;   Questionnaire ratings of anxiety and depression and withdrawal symptoms
16 Unknown  Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder in Veterans of Operation Enduring Freedom and Iraqi Freedom
Conditions: Autonomic Reactivity;   Cardiac Functioning
Intervention: Drug: Escitalopram
Outcome Measures: 1. To investigate the effects of Escitalopram on cardiac vagal function as measured by R-R interval variability, especially in the HF (0.15-0.5 Hz) band in OEF/OIF veterans with PTSD;   2. To investigate the effects of Escitalopram on an absolute or relative decrease in cardiac sympathetic function and serious cardiac side effects as measured by QT interval variability in OEF/OIF veterans with PTSD.;   1. To determine the effectiveness of Escitalopram in OEF/OIF veterans with PTSD
17 Recruiting Investigation of Tibolone and Escitalopram in Perimenopausal Depression
Condition: Perimenopausal Depression
Interventions: Drug: Tibolone;   Drug: Escitalopram;   Drug: Natvia
Outcome Measures: Montgomery and Asberg Depression Rating Scale;   Short Form-36 Health Survey (SF-36);   Pittsburgh Sleep Quality Index;   Adverse Symptoms Checklist;   Beck Depression Inventory Scale
18 Unknown  Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene
Condition: Pharmacokinetics
Intervention: Drug: Escitalopram
Outcome Measures: Brain levels of Escitalopram as assessed by a 19-F magnetic resonance spectroscopy;   Sleep-EEG, functional MRI, learning, gene expression, metabolic changes
19 Recruiting DECIFER: DEpression and Citalopram In First Episode Recovery
Conditions: Schizophrenia;   Schizophreniform Disorder
Interventions: Drug: Citalopram;   Behavioral: Psychoeducation;   Behavioral: Cognitive Behavioral Therapy (CBT);   Radiation: Functional Magnetic Resonance Imaging (fMRI);   Drug: Placebo
Outcome Measures: Calgary Depression Scale for Schizophrenia (CDSS);   Scale for the Assessment of Negative Symptoms (SANS);   Brief Psychiatric Rating Scale (BPRS);   InterSePT Scale for Suicidal Thinking (ISST);   Heinrich Quality of Life Scale (QOL)
20 Unknown  Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
Conditions: Major Depression;   Pain;   Abdominal Pain
Interventions: Drug: Escitalopram;   Drug: Reboxetine;   Other: No intervention
Outcome Measure: rectal distension Transcutaneous Electrical Neuro-Stimulation